| Insideraktier | 13 917 858 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Verve Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i VERV / Verve Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i VERV / Verve Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-28 | 2025-07-25 | 4 | GV 2017 GP, L.L.C. By GV 2023, L.P. | VERV | Common Stock | I | −1 800 000 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | −4 260 047 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | GV 2017 GP, L.L.C. By GV 2017 L.P. | VERV | Common Stock | I | −6 108 442 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Politi Jason | VERV | Common Stock | D | −16 405 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Ashe Andrew D. | VERV | Common Stock | D | −348 828 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | ADELMAN BURT A Burt A Adelman 2002 Trust | VERV | Common Stock | I | −428 326 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Lister Troy | VERV | Common Stock | D | −6 952 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Kathiresan Sekar Kathiresan Family 2021 Irrevocable Trust | VERV | Common Stock | I | −240 997 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Kathiresan Sekar Sekar Kathiresan 2021 Irrevocable Trust | VERV | Common Stock | I | −110 997 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Kathiresan Sekar | VERV | Common Stock | D | −348 431 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Nickerson Joan | VERV | Common Stock | D | −17 420 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Dorval Allison | VERV | Common Stock | D | −13 280 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Yeshwant Krishna By GV 2023, L.P. | VERV | Common Stock | I | −1 800 000 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | −4 260 047 | 0 | ||||||
| 2025-07-28 | 2025-07-25 | 4 | Yeshwant Krishna By GV 2017 L.P. | VERV | Common Stock | I | −6 108 442 | 0 | ||||||
| 2025-04-03 | 2025-04-02 | 4 | Lister Troy | VERV | Common Stock | D | 4,1500 | −2 189 | −9 | 6 952 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Lister Troy | VERV | Common Stock | D | 7 340 | 9 141 | ||||||
| 2025-04-03 | 2025-04-02 | 4 | Dorval Allison | VERV | Common Stock | D | 4,1500 | −3 350 | −14 | 13 280 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Dorval Allison | VERV | Common Stock | D | 11 250 | 16 630 | ||||||
| 2025-04-03 | 2025-04-02 | 4 | Politi Jason | VERV | Common Stock | D | 4,1500 | −3 235 | −13 | 14 226 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Politi Jason | VERV | Common Stock | D | 8 815 | 17 461 | ||||||
| 2025-04-03 | 2025-04-02 | 4 | Ashe Andrew D. | VERV | Common Stock | D | 4,1500 | −2 681 | −11 | 348 828 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Ashe Andrew D. | VERV | Common Stock | D | 9 000 | 351 509 | ||||||
| 2025-04-03 | 2025-04-02 | 4 | Nickerson Joan | VERV | Common Stock | D | 4,1500 | −2 777 | −12 | 17 420 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Nickerson Joan | VERV | Common Stock | D | 9 315 | 20 197 | ||||||
| 2025-04-03 | 2025-04-02 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 4,1500 | −9 822 | −41 | 346 686 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 33 000 | 356 508 | ||||||
| 2024-12-04 | 2024-12-04 | 4 | Kathiresan Sekar Sekar Kathiresan 2021 Irrevocable Trust | VERV | Common Stock | I | 30 000 | 110 997 | ||||||
| 2024-12-04 | 2024-12-04 | 4 | Kathiresan Sekar | VERV | Common Stock | D | −30 000 | 323 508 | ||||||
| 2024-12-03 | 2024-12-02 | 4 | Dorval Allison | VERV | Common Stock | D | 5,6400 | −555 | −3 | 5 380 | ||||
| 2024-12-03 | 2024-11-29 | 4 | Dorval Allison | VERV | Common Stock | D | 1 875 | 5 935 | ||||||
| 2024-07-02 | 2024-06-28 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 2,8700 | 30 000 | 86 | 351 128 | ||||
| 2024-06-28 | 3 | Politi Jason | VERV | Common Stock | D | 6 266 | ||||||||
| 2024-06-25 | 3 | Lister Troy | VERV | Common Stock | D | 1 801 | ||||||||
| 2024-05-15 | 2024-05-14 | 4 | Ashe Andrew D. | VERV | Common Stock | D | 6,2600 | 76 000 | 476 | 342 509 | ||||
| 2024-04-03 | 2024-04-02 | 4 | Nickerson Joan | VERV | Common Stock | D | 8,2400 | −1 514 | −12 | 8 659 | ||||
| 2024-04-03 | 2024-04-01 | 4 | Nickerson Joan | VERV | Common Stock | D | 3 315 | 10 173 | ||||||
| 2024-02-09 | 2023-09-18 | 5 | ADELMAN BURT A Burt A Adelman 2002 Trust | VERV | Common Stock | I | 37 168 | 428 326 | ||||||
| 2024-02-09 | 2023-09-18 | 5 | ADELMAN BURT A Burt A Adelman 2021 GRAT | VERV | Common Stock | I | −37 168 | 0 | ||||||
| 2024-02-09 | 2023-08-11 | 5 | ADELMAN BURT A Burt A Adelman 2002 Trust | VERV | Common Stock | I | 266 258 | 391 158 | ||||||
| 2024-02-09 | 2023-08-11 | 5 | ADELMAN BURT A Burt A Adelman 2021 GRAT | VERV | Common Stock | I | −266 258 | 37 168 | ||||||
| 2024-02-09 | 2022-11-07 | 5 | ADELMAN BURT A Burt A Adelman 2002 Trust | VERV | Common Stock | I | 106 200 | 124 900 | ||||||
| 2024-02-09 | 2022-11-07 | 5 | ADELMAN BURT A Burt A Adelman 2021 GRAT | VERV | Common Stock | I | −106 200 | 303 426 | ||||||
| 2023-12-05 | 3 | GV 2023 GP, L.L.C. By GV 2023, L.P. | VERV | Common Stock | I | 1 800 000 | ||||||||
| 2023-12-05 | 2023-12-01 | 4 | Yeshwant Krishna By GV 2023, L.P. | VERV | Common Stock | I | 10,0000 | 1 800 000 | 18 000 | 1 800 000 | ||||
| 2023-12-01 | 2023-11-29 | 4 | Dorval Allison | VERV | Common Stock | D | 11,4500 | −554 | −6 | 4 060 | ||||
| 2023-12-01 | 2023-11-29 | 4 | Dorval Allison | VERV | Common Stock | D | 1 875 | 4 614 | ||||||
| 2023-02-23 | 3 | Nickerson Joan | VERV | Common Stock | D | 5 494 | ||||||||
| 2022-12-16 | 2022-12-14 | 4 | Bellinger Andrew | VERV | Common Stock | D | 2,8700 | 36 000 | 103 | 42 629 | ||||
| 2022-12-02 | 2022-12-01 | 4 | Bellinger Andrew | VERV | Common Stock | D | 22,9500 | −865 | −20 | 6 629 | ||||
| 2022-12-01 | 2022-11-29 | 4 | Dorval Allison | VERV | Common Stock | D | 22,1000 | −554 | −12 | 2 186 | ||||
| 2022-12-01 | 2022-11-29 | 4 | Dorval Allison | VERV | Common Stock | D | 1 875 | 2 740 | ||||||
| 2022-11-08 | 2022-11-04 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 32,9000 | −243 | −8 | 4 260 047 | ||||
| 2022-11-08 | 2022-11-04 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 31,9905 | −650 | −21 | 4 260 290 | ||||
| 2022-11-08 | 2022-11-04 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 31,1180 | −47 690 | −1 484 | 4 260 940 | ||||
| 2022-11-08 | 2022-11-04 | 4 | Yeshwant Krishna By GV 2017 L.P. | VERV | Common Stock | I | −48 583 | 6 108 442 | ||||||
| 2022-11-08 | 2022-11-04 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 32,9000 | −243 | −8 | 4 260 047 | ||||
| 2022-11-08 | 2022-11-04 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 31,9905 | −650 | −21 | 4 260 290 | ||||
| 2022-11-08 | 2022-11-04 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 31,1180 | −47 690 | −1 484 | 4 260 940 | ||||
| 2022-11-08 | 2022-11-04 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 31,1180 | −47 690 | −1 484 | 4 260 940 | ||||
| 2022-11-08 | 2022-11-04 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 32,9000 | −242 | −8 | 0 | ||||
| 2022-11-08 | 2022-11-04 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 31,9905 | −651 | −21 | 242 | ||||
| 2022-11-08 | 2022-11-04 | 4 | GV 2017 GP, L.L.C. By GV 2017 L.P. | VERV | Common Stock | I | −48 583 | 6 108 442 | ||||||
| 2022-11-04 | 2022-11-03 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 33,8373 | −1 755 | −59 | 4 308 630 | ||||
| 2022-11-04 | 2022-11-03 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 33,1384 | −25 534 | −846 | 4 310 385 | ||||
| 2022-11-04 | 2022-11-03 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 32,3155 | −22 279 | −720 | 4 335 919 | ||||
| 2022-11-04 | 2022-11-03 | 4 | Yeshwant Krishna By GV 2017 L.P. | VERV | Common Stock | I | −49 569 | 6 157 025 | ||||||
| 2022-11-04 | 2022-11-02 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 36,7750 | −8 930 | −328 | 4 358 198 | ||||
| 2022-11-04 | 2022-11-02 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 36,2786 | −10 372 | −376 | 4 367 128 | ||||
| 2022-11-04 | 2022-11-02 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 34,7754 | −9 350 | −325 | 4 377 500 | ||||
| 2022-11-04 | 2022-11-02 | 4 | Yeshwant Krishna By GV 2017 L.P. | VERV | Common Stock | I | −28 651 | 6 206 594 | ||||||
| 2022-11-04 | 2022-11-03 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 33,8373 | −1 755 | −59 | 4 308 630 | ||||
| 2022-11-04 | 2022-11-03 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 33,8373 | −1 755 | −59 | 4 308 630 | ||||
| 2022-11-04 | 2022-11-03 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 33,1384 | −25 534 | −846 | 4 310 385 | ||||
| 2022-11-04 | 2022-11-03 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 32,3155 | −22 279 | −720 | 4 335 919 | ||||
| 2022-11-04 | 2022-11-03 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 32,3155 | −22 279 | −720 | 4 335 919 | ||||
| 2022-11-04 | 2022-11-03 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 33,1384 | −25 535 | −846 | 1 755 | ||||
| 2022-11-04 | 2022-11-03 | 4 | GV 2017 GP, L.L.C. By GV 2017 L.P. | VERV | Common Stock | I | −49 569 | 6 157 025 | ||||||
| 2022-11-04 | 2022-11-02 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 36,7750 | −8 930 | −328 | 4 358 198 | ||||
| 2022-11-04 | 2022-11-02 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 36,7750 | −8 930 | −328 | 4 358 198 | ||||
| 2022-11-04 | 2022-11-02 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 36,2786 | −10 372 | −376 | 4 367 128 | ||||
| 2022-11-04 | 2022-11-02 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 36,2786 | −10 372 | −376 | 4 367 128 | ||||
| 2022-11-04 | 2022-11-02 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 34,7754 | −9 350 | −325 | 4 377 500 | ||||
| 2022-11-04 | 2022-11-02 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 34,7754 | −9 349 | −325 | 19 302 | ||||
| 2022-11-04 | 2022-11-02 | 4 | GV 2017 GP, L.L.C. By GV 2017 L.P. | VERV | Common Stock | I | −28 651 | 6 206 594 | ||||||
| 2022-11-02 | 2022-11-01 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 38,6385 | −260 | −10 | 4 386 850 | ||||
| 2022-11-02 | 2022-11-01 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 37,8210 | −2 377 | −90 | 4 387 110 | ||||
| 2022-11-02 | 2022-11-01 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 36,6878 | −29 326 | −1 076 | 4 389 487 | ||||
| 2022-11-02 | 2022-11-01 | 4 | Yeshwant Krishna By GV 2017 L.P. | VERV | Common Stock | I | −31 963 | 6 235 245 | ||||||
| 2022-11-02 | 2022-10-31 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 40,6445 | −88 | −4 | 4 418 813 | ||||
| 2022-11-02 | 2022-10-31 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 40,1569 | −6 601 | −265 | 4 418 901 | ||||
| 2022-11-02 | 2022-10-31 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 38,9432 | −23 275 | −906 | 4 425 502 | ||||
| 2022-11-02 | 2022-10-31 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 37,9061 | −23 732 | −900 | 4 448 777 | ||||
| 2022-11-02 | 2022-10-31 | 4 | Yeshwant Krishna By GV 2017 L.P. | VERV | Common Stock | I | −53 697 | 6 267 208 | ||||||
| 2022-11-02 | 2022-11-01 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 38,6385 | −260 | −10 | 4 386 850 | ||||
| 2022-11-02 | 2022-11-01 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 38,6385 | −260 | −10 | 4 386 850 | ||||
| 2022-11-02 | 2022-11-01 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 37,8210 | −2 377 | −90 | 4 387 110 | ||||
| 2022-11-02 | 2022-11-01 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 37,8210 | −2 377 | −90 | 4 387 110 | ||||
| 2022-11-02 | 2022-11-01 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 36,6878 | −29 326 | −1 076 | 4 389 487 | ||||
| 2022-11-02 | 2022-11-01 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 36,6878 | −29 326 | −1 076 | 4 389 487 | ||||
| 2022-11-02 | 2022-11-01 | 4 | GV 2017 GP, L.L.C. By GV 2017 L.P. | VERV | Common Stock | I | −31 963 | 6 235 245 | ||||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 40,6445 | −88 | −4 | 4 418 813 | ||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 40,6445 | −88 | −4 | 4 418 813 | ||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 40,1569 | −6 601 | −265 | 4 418 901 | ||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 40,1569 | −6 601 | −265 | 4 418 901 | ||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 38,9432 | −23 275 | −906 | 4 425 502 | ||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 37,9061 | −23 732 | −900 | 4 448 777 | ||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 37,9061 | −23 732 | −900 | 4 448 777 | ||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By Alphabet Holdings LLC | VERV | Common Stock | I | 38,9432 | −23 276 | −906 | 6 689 | ||||
| 2022-11-02 | 2022-10-31 | 4 | GV 2017 GP, L.L.C. By GV 2017 L.P. | VERV | Common Stock | I | −53 697 | 6 267 208 | ||||||
| 2022-11-01 | 2022-10-28 | 4 | Bellinger Andrew | VERV | Common Stock | D | 39,9000 | −10 000 | −399 | 6 629 | ||||
| 2022-11-01 | 2022-10-28 | 4 | Bellinger Andrew | VERV | Common Stock | D | 1,4800 | 10 000 | 15 | 16 629 | ||||
| 2022-10-05 | 2022-10-03 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 34,9723 | −9 904 | −346 | 317 839 | ||||
| 2022-10-05 | 2022-10-03 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 34,1296 | −11 185 | −382 | 327 743 | ||||
| 2022-10-05 | 2022-10-03 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 33,0157 | −28 911 | −955 | 338 928 | ||||
| 2022-10-05 | 2022-10-03 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 1,3900 | 50 000 | 70 | 367 839 | ||||
| 2022-09-27 | 2022-09-23 | 4 | Bellinger Andrew | VERV | Common Stock | D | 36,0336 | −3 202 | −115 | 6 629 | ||||
| 2022-09-27 | 2022-09-23 | 4 | Bellinger Andrew | VERV | Common Stock | D | 35,3091 | −36 798 | −1 299 | 9 831 | ||||
| 2022-09-27 | 2022-09-23 | 4 | Bellinger Andrew | VERV | Common Stock | D | 1,4800 | 40 000 | 59 | 46 629 | ||||
| 2022-09-27 | 2022-09-23 | 4 | Bellinger Andrew | VERV | Common Stock | D | 35,5927 | −13 368 | −476 | 6 629 | ||||
| 2022-09-27 | 2022-09-23 | 4 | Bellinger Andrew | VERV | Common Stock | D | 34,6660 | −6 632 | −230 | 19 997 | ||||
| 2022-09-27 | 2022-09-23 | 4 | Bellinger Andrew | VERV | Common Stock | D | 1,4800 | 20 000 | 30 | 26 629 | ||||
| 2022-08-29 | 2022-08-25 | 4 | Ashe Andrew D. | VERV | Common Stock | D | 2,8700 | 10 835 | 31 | 266 509 | ||||
| 2022-08-29 | 2022-08-25 | 4 | Ashe Andrew D. | VERV | Common Stock | D | 1,4800 | 33 749 | 50 | 255 674 | ||||
| 2022-08-29 | 2022-08-25 | 4 | Ashe Andrew D. | VERV | Common Stock | D | 1,3900 | 51 203 | 71 | 221 925 | ||||
| 2022-08-11 | 2022-08-10 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 29,9000 | −50 000 | −1 495 | 317 839 | ||||
| 2022-08-11 | 2022-08-10 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 1,3900 | 50 000 | 70 | 367 839 | ||||
| 2022-07-22 | 2022-07-20 | 4 | Bellinger Andrew | VERV | Common Stock | D | 34,9000 | −20 000 | −698 | 6 629 | ||||
| 2022-07-22 | 2022-07-20 | 4 | Bellinger Andrew | VERV | Common Stock | D | 1,3900 | 20 000 | 28 | 26 629 | ||||
| 2022-07-21 | 2022-07-19 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 29,9000 | −50 000 | −1 495 | 317 839 | ||||
| 2022-07-21 | 2022-07-19 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 1,3900 | 50 000 | 70 | 367 839 | ||||
| 2022-07-15 | 2022-07-07 | 4 | Kathiresan Sekar Kathiresan Family 2021 Irrevocable Trust | VERV | Common Stock | I | 160 000 | 240 997 | ||||||
| 2022-07-15 | 2022-07-07 | 4 | Kathiresan Sekar | VERV | Common Stock | D | −160 000 | 317 839 | ||||||
| 2022-07-15 | 2022-07-13 | 4 | Bellinger Andrew | VERV | Common Stock | D | 24,9000 | −10 000 | −249 | 6 629 | ||||
| 2022-07-15 | 2022-07-13 | 4 | Bellinger Andrew | VERV | Common Stock | D | 1,4800 | 10 000 | 15 | 16 629 | ||||
| 2022-07-14 | 2022-07-12 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 22,0400 | −63 000 | −1 389 | 570 729 | ||||
| 2022-07-14 | 2022-07-12 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 19,9800 | −100 000 | −1 998 | 633 729 | ||||
| 2022-07-06 | 2022-07-01 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 15,6600 | −38 775 | −607 | 773 729 | ||||
| 2022-07-01 | 2022-06-30 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 15,2100 | −18 810 | −286 | 772 504 | ||||
| 2022-07-01 | 2022-06-29 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 15,6000 | −30 362 | −474 | 791 314 | ||||
| 2022-07-01 | 2022-06-29 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 15,5000 | −4 047 | −63 | 821 676 | ||||
| 2022-05-13 | 2022-05-12 | 4 | ADELMAN BURT A Burt A Adelman 2002 Trust | VERV | Common Stock | I | 12,1526 | 10 000 | 122 | 18 700 | ||||
| 2022-03-22 | 2022-03-18 | 4 | Kathiresan Sekar | VERV | Stock Option (right to buy) | D | 2,87 | −69 674 | 605 308 | |||||
| 2022-03-22 | 2022-03-18 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 2,8700 | 69 674 | 200 | 477 525 | ||||
| 2022-03-17 | 2022-03-15 | 4 | ADELMAN BURT A Burt A Adelman 2002 Trust | VERV | Common Stock | I | 21,3838 | 4 000 | 86 | 8 700 | ||||
| 2022-03-11 | 2022-03-09 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 29,0100 | −3 971 | −115 | 825 723 | ||||
| 2022-02-15 | 2022-02-11 | 4 | Dorval Allison | VERV | Stock Option (right to buy) | D | 30,94 | 60 000 | 60 000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Kathiresan Sekar | VERV | Stock Option (right to buy) | D | 30,94 | 332 000 | 332 000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Bellinger Andrew | VERV | Stock Option (right to buy) | D | 30,94 | 125 000 | 125 000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Ashe Andrew D. | VERV | Stock Option (right to buy) | D | 30,94 | 125 000 | 125 000 | |||||
| 2022-02-11 | 2022-02-09 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 29,4600 | −13 190 | −389 | 829 694 | ||||
| 2022-02-03 | 2022-02-01 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 29,0400 | −35 574 | −1 033 | 842 884 | ||||
| 2022-01-28 | 2022-01-27 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 30,0200 | −247 | −7 | 878 458 | ||||
| 2022-01-28 | 2022-01-27 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 29,2600 | −8 736 | −256 | 878 705 | ||||
| 2022-01-28 | 2022-01-26 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 31,9600 | −45 946 | −1 468 | 887 441 | ||||
| 2022-01-28 | 2022-01-26 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 31,1200 | −88 989 | −2 769 | 933 387 | ||||
| 2022-01-28 | 2022-01-26 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 29,6700 | −14 918 | −443 | 1 022 376 | ||||
| 2022-01-06 | 2022-01-04 | 4 | Kathiresan Sekar | VERV | Stock Option (right to buy) | D | 1,39 | −1 870 | 267 425 | |||||
| 2022-01-06 | 2022-01-04 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 39,9000 | −1 870 | −75 | 406 536 | ||||
| 2022-01-06 | 2022-01-04 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 1,3900 | 1 870 | 3 | 408 406 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Kathiresan Sekar | VERV | Stock Option (right to buy) | D | 1,39 | −6 693 | 269 295 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 39,9000 | −6 693 | −267 | 406 536 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 1,3900 | 6 693 | 9 | 413 229 | ||||
| 2021-12-29 | 2021-12-27 | 4 | Kathiresan Sekar | VERV | Stock Option (right to buy) | D | 1,39 | −42 000 | 275 988 | |||||
| 2021-12-29 | 2021-12-27 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 42,2106 | −770 | −33 | 406 536 | ||||
| 2021-12-29 | 2021-12-27 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 41,2431 | −4 787 | −197 | 407 306 | ||||
| 2021-12-29 | 2021-12-27 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 40,0228 | −36 443 | −1 459 | 412 093 | ||||
| 2021-12-29 | 2021-12-27 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 1,3900 | 42 000 | 58 | 448 536 | ||||
| 2021-12-28 | 3 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 1 037 294 | ||||||||
| 2021-12-27 | 2021-12-22 | 4 | Bellinger Andrew | VERV | Stock Option (right to buy) | D | 1,48 | −15 000 | 146 995 | |||||
| 2021-12-27 | 2021-12-22 | 4 | Bellinger Andrew | VERV | Common Stock | D | 39,3749 | −4 871 | −192 | 5 000 | ||||
| 2021-12-27 | 2021-12-22 | 4 | Bellinger Andrew | VERV | Common Stock | D | 38,6020 | −8 161 | −315 | 9 871 | ||||
| 2021-12-27 | 2021-12-22 | 4 | Bellinger Andrew | VERV | Common Stock | D | 37,4202 | −1 968 | −74 | 18 032 | ||||
| 2021-12-27 | 2021-12-22 | 4 | Bellinger Andrew | VERV | Common Stock | D | 1,4800 | 15 000 | 22 | 20 000 | ||||
| 2021-12-27 | 2021-12-23 | 4 | Kathiresan Sekar | VERV | Stock Option (right to buy) | D | 1,39 | −57 000 | 317 988 | |||||
| 2021-12-27 | 2021-12-23 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 39,9000 | −57 000 | −2 274 | 406 536 | ||||
| 2021-12-27 | 2021-12-23 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 1,3900 | 57 000 | 79 | 463 536 | ||||
| 2021-12-27 | 2021-12-22 | 4 | Kathiresan Sekar | VERV | Stock Option (right to buy) | D | 1,39 | −57 000 | 374 988 | |||||
| 2021-12-27 | 2021-12-22 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 39,7783 | −3 269 | −130 | 406 536 | ||||
| 2021-12-27 | 2021-12-22 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 39,0564 | −31 139 | −1 216 | 409 805 | ||||
| 2021-12-27 | 2021-12-22 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 38,3139 | −16 718 | −641 | 440 944 | ||||
| 2021-12-27 | 2021-12-22 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 37,3782 | −5 874 | −220 | 457 662 | ||||
| 2021-12-27 | 2021-12-22 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 1,3900 | 57 000 | 79 | 463 536 | ||||
| 2021-12-17 | 2021-12-16 | 4 | Bellinger Andrew | VERV | Stock Option (right to buy) | D | 34,88 | 55 000 | 55 000 | |||||
| 2021-12-06 | 2021-12-02 | 4 | Ashe Andrew D. | VERV | Common Stock | D | 32,1049 | 4 000 | 128 | 170 722 | ||||
| 2021-12-06 | 2021-12-02 | 4 | ADELMAN BURT A Burt A Adelman 2002 Trust | VERV | Common Stock | I | 31,3412 | 4 700 | 147 | 4 700 | ||||
| 2021-11-30 | 2021-11-29 | 4 | Dorval Allison | VERV | Restricted Stock Units | D | 7 500 | 7 500 | ||||||
| 2021-11-30 | 2021-11-29 | 4 | Dorval Allison | VERV | Stock Option (right to buy) | D | 33,25 | 135 000 | 135 000 | |||||
| 2021-06-23 | 2021-06-21 | 4 | Broad Institute, Inc. | VERV | Common Stock | D | 387 830 | 809 784 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | Beam Therapeutics Inc. | VERV | Series A Convertible Preferred Stock | D | −2 508 361 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | Beam Therapeutics Inc. | VERV | Common Stock | D | 270 895 | 546 970 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | ARCH Venture Partners X, LLC See Footnotes | VERV | Series A-2 Convertible Preferred Stock | I | −4 508 146 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | ARCH Venture Partners X, LLC See Footnotes | VERV | Series A-2 Convertible Preferred Stock | I | −4 508 144 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | ARCH Venture Partners X, LLC See Footnotes | VERV | Series A Convertible Preferred Stock | I | −7 107 023 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | ARCH Venture Partners X, LLC See Footnotes | VERV | Series A Convertible Preferred Stock | I | −7 107 024 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | ARCH Venture Partners X, LLC ARCH Venture Fund X Overage, L.P. | VERV | Common Stock, par value $0.001 | I | 1 254 405 | 1 254 405 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | ARCH Venture Partners X, LLC ARCH Venture Fund X, L.P. | VERV | Common Stock, par value $0.001 | I | 1 254 404 | 1 254 404 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | Redmile Group, LLC | VERV | Series B Convertible Preferred Stock | I | −8 208 832 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | Redmile Group, LLC | VERV | Common Stock | I | 19,0000 | 1 050 000 | 19 950 | 1 936 530 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Redmile Group, LLC | VERV | Common Stock | I | 886 530 | 886 530 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | Cormorant Asset Management, LLC See Footnotes | VERV | Series B Convertible Preferred Stock | I | −709 224 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | Cormorant Asset Management, LLC See Footnotes | VERV | Common Stock | I | 19,0000 | 275 000 | 5 225 | 984 224 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Cormorant Asset Management, LLC See Footnotes | VERV | Common Stock | I | 709 224 | 709 224 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Series A Preferred Stock | I | −8 361 204 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Series A-2 Preferred Stock | I | −1 243 626 | 0 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 902 986 | 1 037 294 | ||||||
| 2021-06-23 | 2021-06-21 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP | VERV | Common Stock | I | 134 308 | 134 308 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Logos Global Management LP See Footnotes | VERV | Series B Preferred Stock | I | −4 104 416 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Logos Global Management LP | VERV | Common Stock | D | 19,0000 | 370 000 | 7 030 | 370 000 | ||||
| 2021-06-22 | 2021-06-21 | 4 | Logos Global Management LP See Footnotes | VERV | Common Stock | I | 443 265 | 443 265 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | GV 2017 GP, L.L.C. By GV 2017, L.P. | VERV | Series A Preferred Stock | I | −58 528 428 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | GV 2017 GP, L.L.C. By GV 2017, L.P. | VERV | Common Stock | I | 6 320 905 | 6 320 905 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Rock Springs Capital Management LP | VERV | Series B Preferred Stock | I | −1 416 023 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Rock Springs Capital Management LP | VERV | Series B Preferred Stock | I | −5 151 043 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Rock Springs Capital Management LP | VERV | Common Stock | I | 152 926 | 152 926 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Rock Springs Capital Management LP | VERV | Common Stock | I | 19,0000 | 370 000 | 7 030 | 926 298 | ||||
| 2021-06-22 | 2021-06-21 | 4 | Rock Springs Capital Management LP | VERV | Common Stock | I | 556 298 | 556 298 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Novo A/S | VERV | SERIES B CONVERTIBLE PREFERRED STOCK | D | −443 265 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Novo A/S | VERV | COMMON STOCK | D | 19,0000 | 350 000 | 6 650 | 793 265 | ||||
| 2021-06-22 | 2021-06-21 | 4 | Novo A/S | VERV | COMMON STOCK | D | 443 265 | 443 265 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | GV 2019 GP, L.L.C. By GV 2019 L.P. | VERV | Series B Preferred Stock | I | −4 104 416 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | GV 2019 GP, L.L.C. By GV 2019 L.P. | VERV | Series A-2 Preferred Stock | I | −37 308 792 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | GV 2019 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 443 265 | 4 472 509 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | GV 2019 GP, L.L.C. By GV 2019 L.P. | VERV | Common Stock | I | 4 029 244 | 4 029 244 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Series B Preferred Stock | I | −4 104 416 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Series A-2 Preferred Stock | I | −37 308 792 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Yeshwant Krishna By GV 2017, L.P. | VERV | Series A Preferred Stock | I | −58 528 428 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 443 265 | 4 472 509 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Yeshwant Krishna By GV 2019 L.P. | VERV | Common Stock | I | 4 029 244 | 4 029 244 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Yeshwant Krishna By GV 2017, L.P. | VERV | Common Stock | I | 6 320 905 | 6 320 905 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | VERV | Series B Preferred Stock | D | −10 671 482 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | VERV | Series A-2 Preferred Stock | D | −12 436 264 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | VERV | Common Stock | D | 1 152 490 | 2 495 571 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | VERV | Common Stock | D | 1 343 081 | 1 343 081 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Casdin Partners Master Fund, L.P. | VERV | Series B Preferred Stock | D | −2 873 091 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Casdin Partners Master Fund, L.P. | VERV | Series A-2 Preferred Stock | D | −9 327 198 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Casdin Partners Master Fund, L.P. | VERV | Common Stock | D | 19,0000 | 1 100 000 | 20 900 | 2 417 596 | ||||
| 2021-06-22 | 2021-06-21 | 4 | Casdin Partners Master Fund, L.P. | VERV | Common Stock | D | 310 285 | 1 317 596 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Casdin Partners Master Fund, L.P. | VERV | Common Stock | D | 1 007 311 | 1 007 311 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Casdin Private Growth Equity Fund, L.P. | VERV | Series B Preferred Stock | D | −5 746 183 | 0 | ||||||
| 2021-06-22 | 2021-06-21 | 4 | Casdin Private Growth Equity Fund, L.P. | VERV | Common Stock | D | 620 571 | 620 571 | ||||||
| 2021-06-21 | 2021-06-21 | 4 | Beaudoin Margaret | VERV | Common Stock | D | 19,0000 | 1 000 | 19 | 1 000 | ||||
| 2021-06-21 | 2021-06-17 | 4 | Beaudoin Margaret | VERV | Stock Option (right to buy) | D | 19,00 | 10 799 | 10 799 | |||||
| 2021-06-21 | 2021-06-21 | 4 | Bellinger Andrew | VERV | Common Stock | D | 19,0000 | 5 000 | 95 | 5 000 | ||||
| 2021-06-21 | 2021-06-17 | 4 | Bellinger Andrew | VERV | Stock Option (right to buy) | D | 19,00 | 21 599 | 21 599 | |||||
| 2021-06-21 | 2021-06-17 | 4 | MacLean Michael F | VERV | Stock Option (right to buy) | D | 19,00 | 47 664 | 47 664 | |||||
| 2021-06-21 | 2021-06-21 | 4 | Kathiresan Sekar | VERV | Common Stock | D | 19,0000 | 2 500 | 48 | 406 536 | ||||
| 2021-06-21 | 2021-06-17 | 4 | Kathiresan Sekar | VERV | Stock Option (right to buy) | D | 19,00 | 53 998 | 53 998 | |||||
| 2021-06-21 | 2021-06-17 | 4 | Ashe Andrew D. | VERV | Stock Option (right to buy) | D | 19,00 | 21 599 | 21 599 | |||||
| 2021-06-16 | 3 | Beam Therapeutics Inc. | VERV | Common Stock | D | 276 075 | ||||||||
| 2021-06-16 | 3 | Joung Jae Keith By Jae Keith Joung 2017 Irrevocable Trust | VERV | Common Stock | I | 102 406 | ||||||||
| 2021-06-16 | 3 | Joung Jae Keith By MMK Tech LLC | VERV | Common Stock | I | 307 219 | ||||||||
| 2021-06-16 | 3 | Kathiresan Sekar Sekar Kathiresan 2021 Irrevocable Trust | VERV | Common Stock | I | 80 997 | ||||||||
| 2021-06-16 | 3 | Kathiresan Sekar | VERV | Common Stock | D | 404 036 | ||||||||
| 2021-06-16 | 3 | Kathiresan Sekar Kathiresan Family 2021 Irrevocable Trust | VERV | Common Stock | I | 80 997 | ||||||||
| 2021-06-16 | 3 | Rozen Israel | VERV | Common Stock | D | 409 626 | ||||||||
| 2021-06-16 | 3 | ADELMAN BURT A The Burt A. Adelman 2021 GRAT | VERV | Common Stock | I | 409 626 | ||||||||
| 2021-06-16 | 3 | Ticho Barry | VERV | Common Stock | D | 409 626 | ||||||||
| 2021-06-16 | 3 | Ashe Andrew D. | VERV | Common Stock | D | 166 722 | ||||||||
| 2021-06-16 | 3 | Broad Institute, Inc. | VERV | Common Stock | D | 421 954 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
